(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the Euronext session.
The three biggest winners today are CABKA EUR 12W, BARBARA BUI, and IDEX BIOMETRICS.
| Financial Asset | Price | Change | Updated (EST) |
|---|---|---|---|
| CABKA EUR 12W (DSCW2.AS) | 0.01 | 62.5% | 2024-03-25 12:01:30 |
| BARBARA BUI (BUI.PA) | 8.60 | 19.44% | 2024-03-25 13:00:14 |
| IDEX BIOMETRICS (IDEX.OL) | 2.88 | 15.29% | 2024-03-25 12:40:42 |
| MOREFIELD GROUP (MORE.AS) | 0.50 | 12.73% | 2024-03-25 12:03:46 |
| DGB GROUP N.V. (DGB.AS) | 0.53 | 12.29% | 2024-03-25 12:01:57 |
| HYDROGENPRO (HYPRO.OL) | 11.82 | 11.3% | 2024-03-25 12:40:36 |
| NX FILTRATION (NXFIL.AS) | 3.32 | 10.12% | 2024-03-25 12:04:04 |
| LATECOERE (LAT.PA) | 0.02 | 10% | 2024-03-25 13:07:15 |
| SEQUANA MEDICAL (SEQUA.BR) | 1.69 | 9.39% | 2024-03-25 12:21:40 |
| MITHRA (MITRA.BR) | 0.26 | 8.33% | 2024-03-25 12:20:51 |
The three biggest losers today are CASINO GUICHARD, RALLYE, and PIERRE VAC BSA ACT.
| Financial Asset | Price | Change | Updated (EST) |
|---|---|---|---|
| CASINO GUICHARD (CO.PA) | 0.27 | -50.22% | 2024-03-25 13:01:13 |
| RALLYE (RAL.PA) | 0.03 | -12.26% | 2024-03-25 13:22:14 |
| PIERRE VAC BSA ACT (VACBS.PA) | 0.09 | -9.41% | 2024-03-25 13:21:47 |
| BASTIDE LE CONFORT (BLC.PA) | 15.24 | -7.86% | 2024-03-25 13:00:20 |
| BORR DRILLING (BORR.OL) | 68.10 | -7.72% | 2024-03-25 12:26:24 |
| GENSIGHT BIOLOGICS (SIGHT.PA) | 0.41 | -7.72% | 2024-03-25 13:05:34 |
| ORPEA (ORP.PA) | 12.31 | -7.02% | 2024-03-25 13:21:19 |
| OREGE (OREGE.PA) | 0.33 | -7% | 2024-03-25 13:21:16 |
| COURTOIS (COUR.PA) | 126.00 | -6.67% | 2024-03-25 13:01:55 |
| MAISONS DU MONDE (MDM.PA) | 4.36 | -6.23% | 2024-03-25 13:07:48 |
Winners today
1. CABKA EUR 12W (DSCW2.AS)
62.5% Price Change
AEX-Index ended the session with CABKA EUR 12W rising 62.5% to €0.01 on Monday, after five successive sessions in a row of losses. AEX-Index jumped 0.09% to €877.15, after two sequential sessions in a row of gains, on what was a somewhat up trend trading session today.
More news about CABKA EUR 12W.
2. BARBARA BUI (BUI.PA)
19.44% Price Change
Barbara Bui SA engages in the manufacture, marketing, and sale of ready-to-wear clothing and accessories for women in France and internationally. The company offers coats, jackets, tops and shirts, T-shirts, mesh, pants, dresses and skirts, leather products, and tailored cloths; and accessories, such as shoes, bags, scarves, and belts. It offers its products through wholesale distributors, as well as online and offline stores. The company was incorporated in 1982 and is based in Paris, France.
CAC 40 ended the session with BARBARA BUI rising 19.44% to €8.60 on Monday, following the last session’s downward trend. CAC 40 slid 0% to €8,151.60, following the last session’s downward trend on what was a somewhat positive trend exchanging session today.
Earnings Per Share
As for profitability, BARBARA BUI has a trailing twelve months EPS of €1.04.
PE Ratio
BARBARA BUI has a trailing twelve months price to earnings ratio of 8.27. Meaning, the purchaser of the share is investing €8.27 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 125.51%.
Moving Average
BARBARA BUI’s value is higher than its 50-day moving average of €8.43 and higher than its 200-day moving average of €8.35.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, BARBARA BUI’s stock is considered to be overbought (>=80).
More news about BARBARA BUI.
3. IDEX BIOMETRICS (IDEX.OL)
15.29% Price Change
IDEX Biometrics ASA, together with its subsidiaries, designs, develops, and sells fingerprint authentication solutions in Norway, Europe, the Middle East, Africa, the Americas, and the Asia-Pacific regions. The company's fingerprint authentication solutions are used primarily in contactless financial payment, access control, and smart cards, as well as card-based devices for the storage of digital currencies. It primarily serves manufacturers of smart cards for financial payment applications and biometric payment card markets. The company was incorporated in 1996 and is headquartered in Oslo, Norway.
Oslo Børs Benchmark Index_GI ended the session with IDEX BIOMETRICS rising 15.29% to €2.88 on Monday, following the last session’s upward trend. Oslo Børs Benchmark Index_GI jumped 0.28% to €1,323.06, after five sequential sessions in a row of gains, on what was a somewhat positive trend exchanging session today.
Earnings Per Share
As for profitability, IDEX BIOMETRICS has a trailing twelve months EPS of kr-1.06.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -155.84%.
Moving Average
IDEX BIOMETRICS’s worth is way above its 50-day moving average of kr1.79 and way higher than its 200-day moving average of kr2.61.
Revenue Growth
Year-on-year quarterly revenue growth declined by 54.5%, now sitting on 4.14M for the twelve trailing months.
Volume
Today’s last reported volume for IDEX BIOMETRICS is 6490780 which is 343.48% above its average volume of 1463600.
More news about IDEX BIOMETRICS.
4. MOREFIELD GROUP (MORE.AS)
12.73% Price Change
Morefield Group N.V. through its subsidiary Kersten Groep BV, engages in the selecting, advising, supplying, and maintaining medical aids for physical disability peoples. The company manufactures orthoses, such as braces and splints. It serves to municipalities, care administration offices, health insurers, and care institutions/care organizations. The company was formerly known as HeadFirst Source Group N.V. and changed its name to Morefield Group N.V. in January 2019. Morefield Group N.V. was incorporated in 1983 and is headquartered in Willemstad, Curaçao.
AEX-Index ended the session with MOREFIELD GROUP rising 12.73% to €0.50 on Monday, following the last session’s upward trend. AEX-Index jumped 0.09% to €877.15, after two consecutive sessions in a row of gains, on what was a somewhat positive trend exchanging session today.
Earnings Per Share
As for profitability, MOREFIELD GROUP has a trailing twelve months EPS of €0.1.
PE Ratio
MOREFIELD GROUP has a trailing twelve months price to earnings ratio of 4.96. Meaning, the purchaser of the share is investing €4.96 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 43.55%.
Yearly Top and Bottom Value
MOREFIELD GROUP’s stock is valued at €0.50 at 21:40 EST, higher than its 52-week high of €0.46.
More news about MOREFIELD GROUP.
5. DGB GROUP N.V. (DGB.AS)
12.29% Price Change
DGB Group N.V. invests in, develops, and manages biodiversity and carbon offset, and nature-based projects for businesses and governments in the Netherlands and internationally. The company offers nature-based solutions comprising the management and use of nature for tackling social and environmental challenges; carbon offsetting projects for reducing carbon footprint of companies; and biodiversity protection and ecosystem services. It also provides ESG reporting and tree integration services. The company was formerly known as Verenigde Nederlandse Compagnie N.V. and changed its name to DGB Group N.V. in January 2018. DGB Group N.V. was founded in 1957 and is based in Haarlemmermeer, the Netherlands.
AEX-Index ended the session with DGB GROUP N.V. rising 12.29% to €0.53 on Monday while AEX-Index jumped 0.09% to €877.15.
Earnings Per Share
As for profitability, DGB GROUP N.V. has a trailing twelve months EPS of €-0.15.
Moving Average
DGB GROUP N.V.’s value is higher than its 50-day moving average of €0.51 and way higher than its 200-day moving average of €0.48.
Yearly Top and Bottom Value
DGB GROUP N.V.’s stock is valued at €0.53 at 21:40 EST, way below its 52-week high of €0.86 and way above its 52-week low of €0.38.
Revenue Growth
Year-on-year quarterly revenue growth declined by 90.9%, now sitting on 1.24M for the twelve trailing months.
More news about DGB GROUP N.V..
6. HYDROGENPRO (HYPRO.OL)
11.3% Price Change
HydrogenPro ASA designs and supplies customized hydrogen plants. It provides high-pressure alkaline electrolysers. The company was incorporated in 2013 and is headquartered in Porsgrunn, Norway.
Oslo Børs Benchmark Index_GI ended the session with HYDROGENPRO rising 11.3% to €11.82 on Monday, after three sequential sessions in a row of gains. Oslo Børs Benchmark Index_GI jumped 0.28% to €1,323.06, after five sequential sessions in a row of gains, on what was a somewhat positive trend exchanging session today.
Earnings Per Share
As for profitability, HYDROGENPRO has a trailing twelve months EPS of kr-0.95.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -14.13%.
Sales Growth
HYDROGENPRO’s sales growth for the current quarter is negative 74.7%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 403.6%, now sitting on 568.23M for the twelve trailing months.
More news about HYDROGENPRO.
7. NX FILTRATION (NXFIL.AS)
10.12% Price Change
NX Filtration N.V. develops, manufactures, and sells hollow fiber membrane modules in Netherlands, Europe, North America, Asia, and internationally. The company offers direct nanofiltration, ultrafiltration, and microfiltration membrane modules that remove bacteria, viruses, micropollutants, color, and selective salts from water without pre-treatment and use of chemicals. It provides HYDRAcap ultrafiltration modules to treat surface water, ground water, sedawater, and wastewaters as pretreatment to reverse osmosis and nanofiltration; and Projection Tool, and intuitive and online platform that enables the rapid and iterative system design for dNF membranes. In addition, the company offers integrated rack design and testing and piloting services. The company was incorporated in 2016 and is headquartered in Enschede, the Netherlands.
AEX-Index ended the session with NX FILTRATION jumping 10.12% to €3.32 on Monday while AEX-Index rose 0.09% to €877.15.
Earnings Per Share
As for profitability, NX FILTRATION has a trailing twelve months EPS of €-0.47.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -17.78%.
Yearly Top and Bottom Value
NX FILTRATION’s stock is valued at €3.32 at 21:40 EST, way under its 52-week high of €11.10 and way higher than its 52-week low of €2.55.
Volume
Today’s last reported volume for NX FILTRATION is 377952 which is 287.47% above its average volume of 97542.
Moving Average
NX FILTRATION’s worth is way under its 50-day moving average of €3.69 and way below its 200-day moving average of €6.82.
Revenue Growth
Year-on-year quarterly revenue growth declined by 9.7%, now sitting on 7.24M for the twelve trailing months.
More news about NX FILTRATION.
8. LATECOERE (LAT.PA)
10% Price Change
Latécoère S.A. designs, manufactures, assembles, and installs aerostructures and interconnection systems in Europe, the United States, Africa, Asia, and internationally. The company operates through Aerostructures and Interconnection systems segments. It also supplies doors, fuselage, wings, empennage, and connecting rods, as well as manufactures wing sub-assemblies and fuselage components, such as sections, tail cones, front fairings, and watertight bulkheads. In addition, the company offers interconnection systems components comprising of avionics racks, test benches, EWIS and space harnesses; cameras, screens, data transmission solutions; and other electronics. The company was founded in 1917 and is headquartered in Toulouse, France. Latécoère S.A. is a subsidiary of SCP SKN HOLDING I SAS.
CAC 40 ended the session with LATECOERE rising 10% to €0.02 on Monday while CAC 40 dropped 0% to €8,151.60.
Earnings Per Share
As for profitability, LATECOERE has a trailing twelve months EPS of €-0.25.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -311.52%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 45.2%, now sitting on 565.55M for the twelve trailing months.
Moving Average
LATECOERE’s value is way below its 50-day moving average of €0.82 and way below its 200-day moving average of €2.17.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, LATECOERE’s stock is considered to be oversold (<=20).
More news about LATECOERE.
9. SEQUANA MEDICAL (SEQUA.BR)
9.39% Price Change
Sequana Medical NV develops and commercializes treatment of fluid overload in liver disease, cancer, and heart failure. The company's products include alfapump system, an implantable pump system for the treatment of refractory liver ascites and malignant ascites; Direct Sodium Removal (DSR) for the treatment of persistent congestion due to heart failure; and alfapump DSR, a fully implanted system for direct sodium removal therapy in patients with fluid overload due to heart failure. It operates in Belgium, Germany, France, Switzerland, and internationally. The company was founded in 2006 and is headquartered in Ghent, Belgium.
BEL 20 ended the session with SEQUANA MEDICAL jumping 9.39% to €1.69 on Monday while BEL 20 rose 0.2% to €3,811.50.
Earnings Per Share
As for profitability, SEQUANA MEDICAL has a trailing twelve months EPS of €-1.32.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -690.43%.
Moving Average
SEQUANA MEDICAL’s worth is way below its 50-day moving average of €2.87 and way under its 200-day moving average of €3.13.
More news about SEQUANA MEDICAL.
10. MITHRA (MITRA.BR)
8.33% Price Change
Mithra Pharmaceuticals SA develops, manufactures, and markets complex therapeutics in the areas of contraception, menopause, and hormone-dependent cancers in Belgium, Europe and internationally. Its development candidates include Estelle, a combined oral contraceptive that has completed phase III clinical trial; Donesta, which is in phase III clinical trial for estetrol-based oral hormone treatment; and products for neuroprotection and wound healing. The company also develops Myring, a contraceptive vaginal ring releasing a combination of hormones; Tibelia, a tablet composed of tibolone and a synthetic steroid used for hormone therapy in menopause; and Zoreline, a biodegradable subcutaneous implant for use in prostate and breast cancers, and benign gynecological indications. In addition, it provides products in polymeric forms, implants, sterile injectable products, and hormonal tablets. The company was founded in 1999 and is headquartered in Liège, Belgium.
BEL 20 ended the session with MITHRA jumping 8.33% to €0.26 on Monday while BEL 20 rose 0.2% to €3,811.50.
Earnings Per Share
As for profitability, MITHRA has a trailing twelve months EPS of €-1.41.
Volatility
MITHRA’s last week, last month’s, and last quarter’s current intraday variation average was a positive 3.41%, a negative 4.87%, and a positive 5.59%.
MITHRA’s highest amplitude of average volatility was 3.41% (last week), 6.97% (last month), and 5.59% (last quarter).
Revenue Growth
Year-on-year quarterly revenue growth declined by 40.5%, now sitting on 40.16M for the twelve trailing months.
More news about MITHRA.
Losers Today
1. CASINO GUICHARD (CO.PA)
-50.22% Price Change
Casino, Guichard-Perrachon S.A. operates as a food retailer in France, Latin America, and internationally. The company operates hypermarkets, supermarkets, shopping malls, and e-commerce sites, as well as convenience, discount, and cash and carry stores. It also involved in banking, digital marketing, service station, franchise, real estate asset management, property development and trading, rental, banking, and energy-related activities. It operates through stores. The company was founded in 1898 and is based in Saint-Étienne, France.Casino, Guichard-Perrachon S.A operates as a subsidiary of Rallye SA.
CAC 40 ended the session with CASINO GUICHARD sliding 50.22% to €0.27 on Monday, following the last session’s downward trend. CAC 40 slid 0% to €8,151.60, following the last session’s downward trend on what was a somewhat positive trend exchanging session today.
Earnings Per Share
As for profitability, CASINO GUICHARD has a trailing twelve months EPS of €-24.17.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -130.2%.
Volume
Today’s last reported volume for CASINO GUICHARD is 9681950 which is 998.75% above its average volume of 881176.
More news about CASINO GUICHARD.
2. RALLYE (RAL.PA)
-12.26% Price Change
Rallye SA, together with its subsidiaries, engages in the food and non-food e-commerce retailing business in France and internationally. The company operates in two segments, Food and General Retailing, and Holdings and Other Activities. It operates hypermarkets, supermarkets, and convenience stores. The company conducts its retailing activities in France primarily under the Casino, Monoprix, and Franprix banners; food retail activities in Brazil, Colombia, Uruguay, and Argentina mainly under the GPA food banners, Éxito, Disco-Devoto, and Libertad banners; and e-commerce comprising Cdiscount and the Cnova N.V. holding company businesses. It is also involved in the financial investment, property development, and energy related activities. The company was founded in 1925 and is headquartered in Paris, France. Rallye SA operates as a subsidiary of Foncière Euris SA.
CAC 40 ended the session with RALLYE sliding 12.26% to €0.03 on Monday while CAC 40 dropped 0% to €8,151.60.
Earnings Per Share
As for profitability, RALLYE has a trailing twelve months EPS of €-12.91.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -71.26%.
Yearly Top and Bottom Value
RALLYE’s stock is valued at €0.03 at 21:40 EST, way under its 52-week high of €2.98 and way higher than its 52-week low of €0.03.
Volatility
RALLYE’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.91%, a negative 1.79%, and a positive 4.47%.
RALLYE’s highest amplitude of average volatility was 1.71% (last week), 4.28% (last month), and 4.47% (last quarter).
More news about RALLYE.
3. PIERRE VAC BSA ACT (VACBS.PA)
-9.41% Price Change
CAC 40 ended the session with PIERRE VAC BSA ACT dropping 9.41% to €0.09 on Monday, after successive sessions in a row of losses. CAC 40 dropped 0% to €8,151.60, following the last session’s downward trend on what was a somewhat bullish trend trading session today.
Yearly Top and Bottom Value
PIERRE VAC BSA ACT’s stock is valued at €0.09 at 21:40 EST, under its 52-week high of €0.10 and way above its 52-week low of €0.08.
More news about PIERRE VAC BSA ACT.
4. BASTIDE LE CONFORT (BLC.PA)
-7.86% Price Change
Bastide Le Confort Médical SA engages in the sale and rental of medical equipment for individuals and health professionals in France and internationally. The company provides medical materials, such as lift chairs, bathroom medical equipment, medical measuring devices, medical pillows, sitting posture aids, senior electrostimulation devices, heating products, comfort shoes, natural food supplement, first aid products, shopping carts, senior telephone, pedalboard for the elderly, pressotherapy devices, technical help, bed tables, medical rooms, sleep apnea devices, electric scooter for people with reduced mobility, wheelchair manual and electric, walker and rollators, and walking sicks; and wellness accessories comprising circulatory stimulators, revivals, relaxation, organic natural massage gel and essential oils, and pedicure and foot care products. It offers incontinence products, including absorbent briefs, compete adult change, anatomical protections, urinary protections, traversable straight protections, disposable pads, support briefs, mesh briefs, adult onesie, feminine protections, hygiene incontinence, and incontinence swimsuits. In addition, it offers rental and services for medical bed, wheelchair, air mattress, patient lift, and verticalizer; and professional equipment, such as consumable for healthcare prodessionals, hygiene and disinfection, care and dressings, diagnosis and self-check, medical equipment, and professional health packs products. Bastide Le Confort Médical SA was founded in 1977 and is headquartered in Caissargues, France.
CAC 40 ended the session with BASTIDE LE CONFORT dropping 7.86% to €15.24 on Monday, after three successive sessions in a row of losses. CAC 40 dropped 0% to €8,151.60, following the last session’s downward trend on what was a somewhat bullish trend trading session today.
Earnings Per Share
As for profitability, BASTIDE LE CONFORT has a trailing twelve months EPS of €2.02.
PE Ratio
BASTIDE LE CONFORT has a trailing twelve months price to earnings ratio of 7.54. Meaning, the purchaser of the share is investing €7.54 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 19.23%.
More news about BASTIDE LE CONFORT.
5. BORR DRILLING (BORR.OL)
-7.72% Price Change
Borr Drilling Limited operates as an offshore drilling contractor to the oil and gas industry worldwide. The company owns, contracts, and operates jack-up drilling rigs for operations in shallow-water areas, including the provision of related equipment and work crews to conduct oil and gas drilling and workover operations for exploration and production. It serves oil and gas exploration and production companies, such as integrated oil companies, state-owned national oil companies, and independent oil and gas companies. The company was formerly known as Magni Drilling Limited and changed its name to Borr Drilling Limited in December 2016. Borr Drilling Limited was incorporated in 2016 and is based in Hamilton, Bermuda.
Oslo Børs Benchmark Index_GI ended the session with BORR DRILLING falling 7.72% to €68.10 on Monday, after two consecutive sessions in a row of gains. Oslo Børs Benchmark Index_GI rose 0.28% to €1,323.06, after five sequential sessions in a row of gains, on what was a somewhat positive trend exchanging session today.
Earnings Per Share
As for profitability, BORR DRILLING has a trailing twelve months EPS of kr0.95.
PE Ratio
BORR DRILLING has a trailing twelve months price to earnings ratio of 71.68. Meaning, the purchaser of the share is investing kr71.68 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -10.24%.
Yearly Top and Bottom Value
BORR DRILLING’s stock is valued at kr68.10 at 21:40 EST, way under its 52-week high of kr91.55 and way above its 52-week low of kr33.10.
Moving Average
BORR DRILLING’s value is way below its 50-day moving average of kr79.98 and above its 200-day moving average of kr68.03.
Volatility
BORR DRILLING’s last week, last month’s, and last quarter’s current intraday variation average was 0.76%, 0.66%, and 2.18%.
BORR DRILLING’s highest amplitude of average volatility was 0.76% (last week), 2.33% (last month), and 2.18% (last quarter).
More news about BORR DRILLING.
6. GENSIGHT BIOLOGICS (SIGHT.PA)
-7.72% Price Change
GenSight Biologics S.A., a clinical-stage biotechnology company, discovers, develops, and commercializes therapies for mitochondrial and neurodegenerative diseases of the eye and central nervous system. The company develops its products through gene therapy-based mitochondrial targeting sequence and optogenetics technology platforms. Its lead product candidates include LUMEVOQ (GS010), a recombinant AAV2-based gene therapy, which is in Phase III clinical trials for the treatment of leber hereditary optic neuropathy caused by a mutated ND4 gene; and GS030, which is in Phase I/II clinical trial for the treatment of retinitis pigmentosa, as well as in preclinical stage to treat dry age-related macular degeneration. The company is also developing products that are in preclinical stage targeting ophthalmic and neurodegenerative diseases. The company was incorporated in 2012 and is headquartered in Paris, France.
CAC 40 ended the session with GENSIGHT BIOLOGICS falling 7.72% to €0.41 on Monday while CAC 40 slid 0% to €8,151.60.
Earnings Per Share
As for profitability, GENSIGHT BIOLOGICS has a trailing twelve months EPS of €-0.63.
Yearly Top and Bottom Value
GENSIGHT BIOLOGICS’s stock is valued at €0.41 at 21:40 EST, way under its 52-week high of €3.88 and higher than its 52-week low of €0.38.
Moving Average
GENSIGHT BIOLOGICS’s worth is way below its 50-day moving average of €0.55 and way below its 200-day moving average of €1.40.
Volume
Today’s last reported volume for GENSIGHT BIOLOGICS is 188447 which is 14.7% above its average volume of 164289.
More news about GENSIGHT BIOLOGICS.
7. ORPEA (ORP.PA)
-7.02% Price Change
ORPEA SA operates nursing homes, assisted-living facilities, post-acute and rehabilitation hospitals, and psychiatric hospitals. Its nursing home facilities provide personalized support services; and logistical and residential services, including accommodation, meals, and laundry and room cleaning, as well as various daily event, entertainment, and therapeutic workshop services. The company's post-acute and rehabilitation hospitals offer services for geriatrics, musculoskeletal, nervous system, cardiovascular, hematology, and oncology conditions, as well as patients in a persistent vegetative state or in a minimally conscious state. Its psychiatric hospitals provide services for the patients with mood disorders, anxiety disorders, obsessive-compulsive disorders, addictions, eating disorders, sleep disorders, personality disorders, ageing-related psychiatric disorders, psychosis, over exhaustion or burn-out, chronic fatigue syndrome, fibromyalgia, psychosomatic conditions, and post-traumatic stress disorder conditions, as well as geriatric, child, young adult, parent-child, and public/private patients psychiatry services. In addition, the company offers home care services, including housekeeping services, such as cleaning, meals, ironing, gardening, and household errands; daily life assistance services comprising day or night supervision, assistance with hygiene tasks, and meal-time assistance; and movement assistance services. The company operates in France, Belgium, Spain, Italy, Ireland, Switzerland, Austria, Germany, the Czech Republic, Poland, the Netherlands, Luxembourg, Portugal, Brazil, Russia, Slovenia, Uruguay, Colombia, Mexico, Chile, Latvia, Croatia, and China. ORPEA SA was founded in 1989 and is headquartered in Puteaux, France.
CAC 40 ended the session with ORPEA dropping 7.02% to €12.31 on Monday while CAC 40 dropped 0% to €8,151.60.
Earnings Per Share
As for profitability, ORPEA has a trailing twelve months EPS of €-4080.91.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -445.48%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 10.7%, now sitting on 4.93B for the twelve trailing months.
Sales Growth
ORPEA’s sales growth is 8% for the ongoing quarter and 8% for the next.
Yearly Top and Bottom Value
ORPEA’s stock is valued at €12.31 at 21:40 EST, way below its 52-week high of €880.09 and way above its 52-week low of €10.10.
More news about ORPEA.
8. OREGE (OREGE.PA)
-7% Price Change
Orege Société Anonyme designs, develops, operates, manufactures, and markets municipal and industrial sludge, and effluents treatment solutions in France, the United States, Japan, Germany, and the United Kingdom. The company offers SLG solution for conditioning, treating, and recovering municipal and industrial sludge; SLG-F, a combination of SLG conditioning solution; and Flosep for sludge separation and thickening tool. It also provides after-sales, installation and commissioning, operator training, warranty extensions, maintenance, and process optimization packages. The company was incorporated in 2005 and is headquartered in Voisins-Le-Bretonneux, France. Orege Société Anonyme is a subsidiary of Eren Groupe SA.
CAC 40 ended the session with OREGE falling 7% to €0.33 on Monday, after two successive sessions in a row of gains. CAC 40 dropped 0% to €8,151.60, following the last session’s downward trend on what was a somewhat bullish trend exchanging session today.
Earnings Per Share
As for profitability, OREGE has a trailing twelve months EPS of €-0.15.
More news about OREGE.
9. COURTOIS (COUR.PA)
-6.67% Price Change
Courtois S.A. renovates and sells real estate properties located in the Midi-Pyrenees and Paris regions in France. Courtois S.A. is based in Toulouse, France.
CAC 40 ended the session with COURTOIS falling 6.67% to €126.00 on Monday, after two sequential sessions in a row of losses. CAC 40 fell 0% to €8,151.60, following the last session’s downward trend on what was a somewhat bullish trend trading session today.
Earnings Per Share
As for profitability, COURTOIS has a trailing twelve months EPS of €-3.12.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -1.17%.
Moving Average
COURTOIS’s worth is below its 50-day moving average of €130.52 and under its 200-day moving average of €129.24.
More news about COURTOIS.
10. MAISONS DU MONDE (MDM.PA)
-6.23% Price Change
Maisons du Monde S.A., through its subsidiaries, provides home and living room related products in France and internationally. The company's decorative products include bed linen products, carpets, candles, pillows and cushions, clocks, tableware, lamps, kitchen utensils, mirrors and frames, vases, storage units, curtains and net curtains, and bath products. It also provides furniture, such as sofas, chairs, beds, mattresses and bedframes, floor lamps, tables, and junior furniture; and tables and storage units comprising bookshelves, wardrobes, and cupboards, as well as outdoor furniture. In addition, the company offers warehouse logistics and order preparation services, as well as container transport services between harbor and warehouses. It provides its products under the Maisons du Monde brand. The company was founded in 1996 and is based in Vertou, France.
CAC 40 ended the session with MAISONS DU MONDE falling 6.23% to €4.36 on Monday, after two consecutive sessions in a row of losses. CAC 40 fell 0% to €8,151.60, following the last session’s downward trend on what was a somewhat up trend trading session today.
Earnings Per Share
As for profitability, MAISONS DU MONDE has a trailing twelve months EPS of €0.67.
PE Ratio
MAISONS DU MONDE has a trailing twelve months price to earnings ratio of 6.51. Meaning, the purchaser of the share is investing €6.51 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.3%.
Moving Average
MAISONS DU MONDE’s value is way below its 50-day moving average of €7.11 and way under its 200-day moving average of €9.29.
More news about MAISONS DU MONDE.
Stay up to date with our winners and losers daily report
